Melanoma and chronic exposure to contraceptives containing microdoses of ethinylestradiol in young women: a retrospective study from the Research on Adverse Drug Events and Reports (RADAR) project comprising a large Midwestern U.S. patient population

Melanoma and chronic exposure to contraceptives containing microdoses of ethinylestradiol in... Dear EditorAn association between the use of contraceptives containing exogenous oestrogen compounds and subsequent diagnosis for malignant melanoma (MM) has been suspected for decades. This is, in part, due to the finding that oestrogen stimulates melanogenesis and the observation that the incidence of MM is greater in women vs. men before the age of 50, but lower than in men after the age of 50, corresponding with the average age of menopause when oestrogen levels dramatically decrease.Prior studies assessing the relationship between the incidence of MM and exposure to exogenous oestrogen provide conflicting results. Moreover, the vast majority of previous reports do not specify the oestrogen‐based dosage form, nor the actual dose of the oestrogenic compound, and typically rely on patient completed questionnaires that are subject to recall bias. Further, over recent decades, the dosage of oestrogenic compounds in hormonal contraceptives has greatly decreased compared to studies of the earliest oestrogenic compounds where an association with MM was reported. Given widespread and chronic use, the aim of this study was to determine whether exposure to contraceptives containing ethinylestradiol (EE) at microdoses (40mcg/day or less) showed an association with MM within a large, urban, Midwestern U.S. patient population served by http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of the European Academy of Dermatology & Venereology Wiley

Melanoma and chronic exposure to contraceptives containing microdoses of ethinylestradiol in young women: a retrospective study from the Research on Adverse Drug Events and Reports (RADAR) project comprising a large Midwestern U.S. patient population

Loading next page...
 
/lp/wiley/melanoma-and-chronic-exposure-to-contraceptives-containing-microdoses-HSt00PJsdh
Publisher
Wiley Subscription Services, Inc., A Wiley Company
Copyright
Copyright © 2018 European Academy of Dermatology and Venereology
ISSN
0926-9959
eISSN
1468-3083
D.O.I.
10.1111/jdv.14534
Publisher site
See Article on Publisher Site

Abstract

Dear EditorAn association between the use of contraceptives containing exogenous oestrogen compounds and subsequent diagnosis for malignant melanoma (MM) has been suspected for decades. This is, in part, due to the finding that oestrogen stimulates melanogenesis and the observation that the incidence of MM is greater in women vs. men before the age of 50, but lower than in men after the age of 50, corresponding with the average age of menopause when oestrogen levels dramatically decrease.Prior studies assessing the relationship between the incidence of MM and exposure to exogenous oestrogen provide conflicting results. Moreover, the vast majority of previous reports do not specify the oestrogen‐based dosage form, nor the actual dose of the oestrogenic compound, and typically rely on patient completed questionnaires that are subject to recall bias. Further, over recent decades, the dosage of oestrogenic compounds in hormonal contraceptives has greatly decreased compared to studies of the earliest oestrogenic compounds where an association with MM was reported. Given widespread and chronic use, the aim of this study was to determine whether exposure to contraceptives containing ethinylestradiol (EE) at microdoses (40mcg/day or less) showed an association with MM within a large, urban, Midwestern U.S. patient population served by

Journal

Journal of the European Academy of Dermatology & VenereologyWiley

Published: Jan 1, 2018

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off